Get the app!
Back to Trades
Sell4

MADRIGAL PHARMACEUTICALS, INC.

MDGL

Total Value
$479.6K
Net $479.6K sold
Sales
$479.6K
8 transactions

Company Information

Ticker Symbol
MDGL
CIK
0001157601

Insider Information

Role
General Counsel
Officer
Location
WEST CONSHOHOCKEN, PA

Filing Details

Filing Date
Aug 18, 2025
Transaction Date
Aug 18, 2025
Accession Number
0002034056-25-000009
Form Type
4
Net Trading Amount
-$479.6K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Aug 18, 2025Common Stock458$358.66Sale$164.3K
Aug 18, 2025Common Stock126$369.64Sale$46.6K
Aug 18, 2025Common Stock84$370.06Sale$31.1K
Aug 18, 2025Common Stock84$371.35Sale$31.2K
Aug 18, 2025Common Stock252$372.44Sale$93.9K
Aug 18, 2025Common Stock68$374.13Sale$25.4K
Aug 18, 2025Common Stock190$375.75Sale$71.4K
Aug 18, 2025Common Stock42$376.62Sale$15.8K

Footnotes

  1. (F1)This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
  2. (F2)This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.
  3. (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.02 to $369.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.22 to $371.48, inclusive.
  5. (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.25 to $372.76, inclusive.
  6. (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.77 to $374.36, inclusive.
  7. (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.46 to $376.06, inclusive.
  8. (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.60 to $376.64, inclusive.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.